Who
Elizabeth E. Tallett
Director
Company insider
Files Form 4 as: Director, Moderna; Director, Elevance Health; Director, Hawkeye Acquisition; Director, Meredith Holdings; Director and Other, Principal Financial Group; Director, Coventry Health Care; Director, Varian; Director, Varian Semiconductor Equipment Associates.
In numbers
- Trades disclosed
- 405
- Buys
- 3
- Sells
- 11
- Bought
- $175K
- Sold
- $3.0M
- Companies
- 9
- Companies where not an officer
- 9
- First trade
- 1 Jan 2006
- Last trade
- 6 May 2026
- Last filed
- 8 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 May 2026filed 8 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,371 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,371 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —4,058 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,058 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,058 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —4,058 | filing |
| 30 Apr 2025filed 1 May 2025 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,134 at $0.00 | filing |
| 30 Apr 2025filed 1 May 2025 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,058 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —388 at $0.00 | filing |
| 6 May 2024filed 7 May 2024 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,557 at $0.00 | filing |
| 10 May 2023filed 12 May 2023 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —457 at $0.00 | filing |
| 3 May 2023filed 5 May 2023 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,134 at $0.00 | filing |
| 18 May 2022filed 20 May 2022 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —440 at $0.00 | filing |
| 28 Apr 2022filed 2 May 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —703 at $0.00 | filing |
| 28 Apr 2022filed 2 May 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,415 at $0.00 | filing |
| 28 Apr 2022filed 2 May 2022 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —703 at $0.00 | filing |
| 1 Dec 2021filed 3 Dec 2021 | Hawkeye Acquisitionoption or derivative | SEC FORM 4 Code D | —8,100 | filing |
| 1 Dec 2021filed 3 Dec 2021 | Hawkeye Acquisitionoption or derivative | SEC FORM 4 Code D | —4,064 | filing |
| 1 Dec 2021filed 3 Dec 2021 | Hawkeye Acquisitionoption or derivative | SEC FORM 4 Code D | —3,912 | filing |
| 1 Dec 2021filed 3 Dec 2021 | Hawkeye Acquisitionoption or derivative | SEC FORM 4 Code D | —4,389 | filing |
News
Actinium Appoints Matt David as CFO and Principal Financial OfficerPFG · econotimes.com · 15 Oct 2026Principal Financial Group (NASDAQ:PFG) Given New $113.00 Price Target at Wells Fargo & CompanyPFG · tickerreport.com · 13 Oct 2026Head to Head Comparison: Yuanbao (NASDAQ:YB) & Principal Financial Group (NASDAQ:PFG)PFG · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Elizabeth E. Tallett; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.